▶ 調査レポート

女性健康診断の世界市場:デバイス種類別(生検デバイス、イメージング・モニタリングシステム、キット・試薬、消耗品・付属品)、検査種類別(乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニング&保因者検査、妊娠検査、生殖能力&排卵検査、感染症検査、その他)、エンドユーザー別(病院、診断研究所・画像センター、専門クリニック、その他)

• 英文タイトル:Women’s Health Diagnostics Market (Device Type: Biopsy Devices, Imaging & Monitoring Systems, Kits & Reagents, and Consumables & Accessories; Test Type: Breast Cancer Testing, Cervical Cancer Testing, Prenatal Genetic Screening & Carrier Testing, Pregnancy Testing, Fertility & Ovulation Testing, Infectious Disease Testing, and Others; and End User: Hospitals, Diagnostic Laboratories & Imaging Centers, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。女性健康診断の世界市場:デバイス種類別(生検デバイス、イメージング・モニタリングシステム、キット・試薬、消耗品・付属品)、検査種類別(乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニング&保因者検査、妊娠検査、生殖能力&排卵検査、感染症検査、その他)、エンドユーザー別(病院、診断研究所・画像センター、専門クリニック、その他) / Women’s Health Diagnostics Market (Device Type: Biopsy Devices, Imaging & Monitoring Systems, Kits & Reagents, and Consumables & Accessories; Test Type: Breast Cancer Testing, Cervical Cancer Testing, Prenatal Genetic Screening & Carrier Testing, Pregnancy Testing, Fertility & Ovulation Testing, Infectious Disease Testing, and Others; and End User: Hospitals, Diagnostic Laboratories & Imaging Centers, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / D0JU09159資料のイメージです。• レポートコード:D0JU09159
• 出版社/出版日:Transparency Market Research / 2020年1月14日
• レポート形態:英文、PDF、204ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥654,835 (USD5,795)▷ お問い合わせ
  Multi User¥993,835 (USD8,795)▷ お問い合わせ
  Corporate License¥1,332,835 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、女性健康診断の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、デバイス種類別(生検デバイス、イメージング・モニタリングシステム、キット・試薬、消耗品・付属品)分析、検査種類別(乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニング&保因者検査、妊娠検査、生殖能力&排卵検査、感染症検査、その他)分析、エンドユーザー別(病院、診断研究所・画像センター、専門クリニック、その他)分析、地域別分析、競争状況などの構成でお届けいたします。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・女性健康診断の世界市場:デバイス種類別(生検デバイス、イメージング・モニタリングシステム、キット・試薬、消耗品・付属品)
・女性健康診断の世界市場:検査種類別(乳がん検査、子宮頸がん検査、出生前遺伝子スクリーニング&保因者検査、妊娠検査、生殖能力&排卵検査、感染症検査、その他)
・女性健康診断の世界市場:エンドユーザー別(病院、診断研究所・画像センター、専門クリニック、その他)
・女性健康診断の世界市場:地域別
・競争状況

Women’s Health Diagnostics Market – Scope of the Report

TMR’s report on the global women’s health diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the mentioned indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the women’s health diagnostics market for the period from 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the women’s health diagnostics market for the forecast period from 2019 to 2027.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Extensive secondary research involved studying key players’ product literature, annual reports, press releases, and relevant documents to understand the women’s health diagnostics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the women’s health diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the women’s health diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the women’s health diagnostics market.

The report delves into the competitive landscape of the women’s health diagnostics market. Key players operating in the women’s health diagnostics market have been identified and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT analysis are some of the attributes of players in the women’s health diagnostics market profiled in this report.

Key Questions Answered in Women’s Health Diagnostics Market Report

How does the development of women’s health diagnostics provide the scope of growth in the women’s health diagnostics market?
How alliances and partnerships between players are widening the scope of new preservation techniques for women’s health diagnostics?
What are the revenue share projections of key segments under various criteria in the women’s health diagnostics market during the forecast period?
Which segment is likely to generate the highest revenue by the end of the forecast period in 2027?
How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall women’s health diagnostics market?
Women’s Health Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the women’s health diagnostics market begins with an overview section, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for women’s health diagnostics.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the women’s health diagnostics market in terms of device type, test type, end user, and region. Key segments under each criteria have been studied at length and the market share for each of these at the end of 2027 has also provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the women’s health diagnostics market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. 3. Executive Summary: Global Women’s Health Diagnostics Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Women’s Health Diagnostics Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Global Women’s Health Diagnostics Market Analysis and Forecast, by Device Type

5.1. Introduction

5.2. Key Findings

5.3. Global Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

5.3.1. Biopsy Devices

5.3.2. Imaging & Monitoring System

5.3.2.1. Ultrasound Devices

5.3.2.2. Mammography Systems

5.3.2.3. MRI Systems

5.3.2.4. Others

5.3.3. Kits & Reagents

5.3.4. Consumables & Accessories

5.4. Global Women’s Health Diagnostics Market Attractiveness, by Device Type

6. Global Women’s Health Diagnostics Market Analysis and Forecast, by Test Type

6.1. Introduction & Definition

6.2. Key Findings

6.3. Global Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

6.3.1. Breast Cancer Testing

6.3.2. Cervical Cancer Testing

6.3.3. Prenatal Genetic Screening & Carrier Testing

6.3.4. Pregnancy Testing

6.3.5. Fertility & Ovulation Testing

6.3.6. Infectious Disease Testing

6.3.7. Others

6.4. Global Women’s Health Diagnostics Market Attractiveness, by Test Type

7. Global Women’s Health Diagnostics Market Analysis and Forecast, by End-user

7.1. Introduction

7.2. Key Findings

7.3. Global Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

7.3.1. Hospitals

7.3.2. Diagnostic Laboratories & Imaging Centers

7.3.3. Specialty Clinics

7.3.4. Others

7.4. Global Women’s Health Diagnostics Market Attractiveness, by End-user

8. Global Women’s Health Diagnostics Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Women’s Health Diagnostics Market Value Forecast, by Region, 2017–2027

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Women’s Health Diagnostics Market Attractiveness, by Region

9. North America Women’s Health Diagnostics Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. North America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

9.2.1. Biopsy Devices

9.2.2. Imaging & Monitoring System

9.2.2.1. Ultrasound Devices

9.2.2.2. Mammography Systems

9.2.2.3. MRI Systems

9.2.2.4. Others

9.2.3. Kits & Reagents

9.2.4. Consumables & Accessories

9.3. North America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

9.3.1. Breast Cancer Testing

9.3.2. Cervical Cancer Testing

9.3.3. Prenatal Genetic Screening & Carrier Testing

9.3.4. Pregnancy Testing

9.3.5. Fertility & Ovulation Testing

9.3.6. Infectious Disease Testing

9.3.7. Others

9.4. North America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

9.4.1. Hospitals

9.4.2. Diagnostic Laboratories & Imaging Centers

9.4.3. Specialty Clinics

9.4.4. Others

9.5. North America Women’s Health Diagnostics Market Value Forecast, by Country, 2017–2027

9.5.1. U.S.

9.5.2. Canada

9.6. North America Women’s Health Diagnostics Market Attractiveness Analysis

9.6.1. By Device Type

9.6.2. By Test Type

9.6.3. By End-user

9.6.4. By Country

10. Europe Women’s Health Diagnostics Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. Europe Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

10.2.1. Biopsy Devices

10.2.2. Imaging & Monitoring System

10.2.2.1. Ultrasound Devices

10.2.2.2. Mammography Systems

10.2.2.3. MRI Systems

10.2.2.4. Others

10.2.3. Kits & Reagents

10.2.4. Consumables & Accessories

10.3. Europe Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

10.3.1. Breast Cancer Testing

10.3.2. Cervical Cancer Testing

10.3.3. Prenatal Genetic Screening & Carrier Testing

10.3.4. Pregnancy Testing

10.3.5. Fertility & Ovulation Testing

10.3.6. Infectious Disease Testing

10.3.7. Others

10.4. Europe Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Diagnostic Laboratories & Imaging Centers

10.4.3. Specialty Clinics

10.4.4. Others

10.5. Europe Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. Germany

10.5.2. U.K.

10.5.3. France

10.5.4. Spain

10.5.5. Italy

10.5.6. Rest of Europe

10.6. Europe Women’s Health Diagnostics Market Attractiveness Analysis

10.6.1. By Device Type

10.6.2. By Test Type

10.6.3. By End-user

10.6.4. By Country/Sub-region

11. Asia Pacific Women’s Health Diagnostics Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

11.2.1. Biopsy Devices

11.2.2. Imaging & Monitoring System

11.2.2.1. Ultrasound Devices

11.2.2.2. Mammography Systems

11.2.2.3. MRI Systems

11.2.2.4. Others

11.2.3. Kits & Reagents

11.2.4. Consumables & Accessories

11.3. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

11.3.1. Breast Cancer Testing

11.3.2. Cervical Cancer Testing

11.3.3. Prenatal Genetic Screening & Carrier Testing

11.3.4. Pregnancy Testing

11.3.5. Fertility & Ovulation Testing

11.3.6. Infectious Disease Testing

11.3.7. Others

11.4. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Diagnostic Laboratories & Imaging Centers

11.4.3. Specialty Clinics

11.4.4. Others

11.5. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. China

11.5.2. Japan

11.5.3. India

11.5.4. Australia & New Zealand

11.5.5. Rest of Asia Pacific

11.6. Asia Pacific Women’s Health Diagnostics Market Attractiveness Analysis

11.6.1. By Device Type

11.6.2. By Test Type

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Latin America Women’s Health Diagnostics Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Latin America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

12.2.1. Biopsy Devices

12.2.2. Imaging & Monitoring System

12.2.2.1. Ultrasound Devices

12.2.2.2. Mammography Systems

12.2.2.3. MRI Systems

12.2.2.4. Others

12.2.3. Kits & Reagents

12.2.4. Consumables & Accessories

12.3. Latin America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

12.3.1. Breast Cancer Testing

12.3.2. Cervical Cancer Testing

12.3.3. Prenatal Genetic Screening & Carrier Testing

12.3.4. Pregnancy Testing

12.3.5. Fertility & Ovulation Testing

12.3.6. Infectious Disease Testing

12.3.7. Others

12.4. Latin America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Diagnostic Laboratories & Imaging Centers

12.4.3. Specialty Clinics

12.4.4. Others

12.5. Latin America Women’s Health Diagnostics Market Attractiveness Analysis

12.5.1. By Device Type

12.5.2. By Test Type

12.5.3. By End-user

12.5.4. By Country/Sub-region

13. Middle East & Africa Women’s Health Diagnostics Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

13.2.1. Biopsy Devices

13.2.2. Imaging & Monitoring System

13.2.2.1. Ultrasound Devices

13.2.2.2. Mammography Systems

13.2.2.3. MRI Systems

13.2.2.4. Others

13.2.3. Kits & Reagents

13.2.4. Consumables & Accessories

13.3. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

13.3.1. Breast Cancer Testing

13.3.2. Cervical Cancer Testing

13.3.3. Prenatal Genetic Screening & Carrier Testing

13.3.4. Pregnancy Testing

13.3.5. Fertility & Ovulation Testing

13.3.6. Infectious Disease Testing

13.3.7. Others

13.4. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Diagnostic Laboratories & Imaging Centers

13.4.3. Specialty Clinics

13.4.4. Others

13.5. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. GCC Countries

13.5.2. South Africa

13.5.3. Rest of Middle East & Africa

13.6. Middle East & Africa Women’s Health Diagnostics Market Attractiveness Analysis

13.6.1. By Device Type

13.6.2. By Test Type

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Competition Landscape

14.1. Market Players – Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis, by Company, 2018

14.3. Company Profiles

14.3.1. Abbott Laboratories

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Financial Overview

14.3.1.3. Product Portfolio

14.3.1.4. SWOT Analysis

14.3.1.5. Strategic Overview

14.3.2. Becton, Dickinson and Company

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Financial Overview

14.3.2.3. Product Portfolio

14.3.2.4. SWOT Analysis

14.3.2.5. Strategic Overview

14.3.3. bioMérieux SA

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Financial Overview

14.3.3.3. Product Portfolio

14.3.3.4. SWOT Analysis

14.3.3.5. Strategic Overview

14.3.4. F. Hoffmann-La Roche AG

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Financial Overview

14.3.4.3. Product Portfolio

14.3.4.4. SWOT Analysis

14.3.4.5. Strategic Overview

14.3.5. GE Healthcare

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Financial Overview

14.3.5.3. Product Portfolio

14.3.5.4. SWOT Analysis

14.3.5.5. Strategic Overview

14.3.6. Hologic, Inc.

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Financial Overview

14.3.6.3. Product Portfolio

14.3.6.4. SWOT Analysis

14.3.6.5. Strategic Overview

14.3.7. Koninklijke Philips N.V.

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Financial Overview

14.3.7.3. Product Portfolio

14.3.7.4. SWOT Analysis

14.3.7.5. Strategic Overview

14.3.8. Quest Diagnostics, Inc.

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Financial Overview

14.3.8.3. Product Portfolio

14.3.8.4. SWOT Analysis

14.3.8.5. Strategic Overview

14.3.9. Cardinal Health

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Financial Overview

14.3.9.3. Product Portfolio

14.3.9.4. SWOT Analysis

14.3.9.5. Strategic Overview

14.3.10. Siemens AG

14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.10.2. Financial Overview

14.3.10.3. Product Portfolio

14.3.10.4. SWOT Analysis

14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 02: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring Systems, 2017–2027

Table 03: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 04: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 05: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 08: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 09: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 10: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 11: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 13: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 14: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 15: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 16: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 18: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 19: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 20: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 21: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 23: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 24: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 25: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 26: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 28: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 29: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 30: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027